Marie-Helene LEOPOLD
Partner
Marie-Hélène Leopold began her career in 1985 at BNP as a Pharma Monde analyst. From 1987 to 1994, she was a Sell-Side Pharma Europe analyst at NatWest Securities, then between 1994 and 2000, she headed the teams of Pharma and Biotech Europe analysts at BNPParibas. In 2000, she became a Partner at Global Private Equity, in charge of raising funds for European private Biotech and MedTech companies. From 2003 to 2007, she led SG Cowen's team of Sell-Side Pharma, Biotech and MedTech analysts. From 2007 to 2018, she was a Buy-Side analyst in charge of the Pharma and MedTech/Healthcare sector at Amundi Asset Management.
​
Marie-Hélène holds a postgraduate degree in Cellular and Molecular Biology and a postgraduate degree in Corporate Finance from Pierre and Marie Curie University. She also obtained a certificate from Johns Hopkins University (USA) on Cancer Biology. From 1987 to 2007, she was head of the Health Sector of the French Society of Financial Analysts (SFAF). She was elected best Pharma Europe analyst in the Extel ranking (2015, 2017) and systematically in the Top 3 between 2008 and 2018. Marie-Hélène is also a certified HEC Executive Coach.
Anne Chofflet
Partner
Anne Chofflet has over 20 years of experience in the sale of institutional equities. She started her career at Banque Harwanne and joined NSM Bank (ABN AMRO Group) where she became Head of Institutional Sales in Europe. In 2004, she founded Finapsis, an independent advisory firm specializing in fundraising for listed and unlisted companies, where she carried out numerous transactions in the healthcare and software sectors.
Anne is a graduate of Reims Management School.
Frédéric GOMEZ
Partner
Frederic Gomez has over 15 years of experience as an Equity Analyst, specialized in the healthcare industry. He was the Head of Business Development at Novagali Pharma (French biotech company focused in ophthalmology acquired by Santen with a premium > 80% of its IPO listing price on Euronext), and as an Analyst at Exane BNP Paribas, developing expertise in financial analysis for biotech and medtech investment. He was involved in IPOs on Euronext, as well as M&A operations.
Frederic graduated from Ecole Supérieure de Commerce de Paris (ESCP) and holds a PharmD from University of Nantes.